Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Artivion, Inc. Common Stock (NY: AORT )

30.06 -0.08 (-0.27%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 141,695
Open 30.22
Bid (Size) 29.50 (2)
Ask (Size) 31.25 (1)
Prev. Close 30.14
Today's Range 29.99 - 30.40
52wk Range 17.63 - 32.33
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers. 
Via StockStory
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including... 
Via StockStory

Performance

YTD
+7.05%
+7.05%
1 Month
-3.78%
-3.78%
3 Month
+12.71%
+12.71%
6 Month
+19.14%
+19.14%
1 Year
+59.81%
+59.81%

More News

Read More
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
Via StockStory
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest
Via StockStory
Where Artivion Stands With Analysts
Via Benzinga
In-Depth Examination Of 6 Analyst Recommendations For Artivion
Via Benzinga
Where Artivion Stands With Analysts
Via Benzinga
Assessing Artivion: Insights From 6 Financial Analysts
Via Benzinga
The Latest Analyst Ratings For Artivion
Via Benzinga
Analyst Scoreboard: 5 Ratings For Artivion
Via Benzinga
AORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
3 Earnings All-Stars With More Room to Run
Via InvestorPlace
A Glimpse Into The Expert Outlook On Artivion Through 4 Analysts
Via Benzinga
Breaking Down Artivion: 4 Analysts Share Their Views
Via Benzinga
Earnings Scheduled For February 15, 2024
Via Benzinga
Artivion's Earnings: A Preview
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
AORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
'Most Suspicious Congressional Stock Trade?' Little-Known Med Tech Firm Surges 48% In Just 2 Months After Senator Tina Smith Bought The Dip
Via Benzinga
Forget Nancy Pelosi, This Democratic Senator Made Up To $55K Profit In Nearly 3 Weeks On This Medical Device Stock That's Lost 40% In Last 5 Years
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.